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Glomerular epithelial cells, or podocytes, 
are an essential part of the glomerular 
ﬁltration barrier that prevents passage of 
proteins of the size of albumin or larger 
from the circulation into glomerular ultra-
filtrate. Podocytes are specialized cells 
that consist of the cell body and primary, 
secondary, and tertiary processes. The 
cytoskeleton of the cell body and major 
processes consists primarily of microtu-
bules and vimentin intermediate ﬁlaments, 
whereas the major cytoskeletal component 
of the tertiary processes, or foot processes, 
is actin microﬁlaments. Actin cytoskeleton 
maintains the architecture of the foot pro-
cesses and responds to signals from outside 
of the podocyte to modify its structural 
and functional characteristics.
Neighboring podocytes are intercon-
nected with a specialized cell adhesion 
structure, the slit diaphragm, that shares 
features reminiscent of both adherens 
and tight junctions. In 1998, upon iden-
tification of nephrin,1 the first integral 
protein of the slit diaphragm, characteri-
zation of the slit diaphragm proteins and 
their functions became a subject of inten-
sive research. Thereafter, several other 
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immunoglobulin superfamily members 
sharing homology with nephrin, as well 
as members of the cadherin superfamily, 
among other proteins, have been localized 
to the slit diaphragm. Importantly, many 
of these proteins are essential for main-
taining the normal podocyte morphology 
and function, as lack of or mutations in, 
for example, nephrin, its binding part-
ners NEPH1, podocin, and CD2AP, or 
the cadherin superfamily member FAT1 
lead to podocyte foot process eﬀacement 
(ﬂattening) (for references, see Johnstone 
and Holzman2). Foot process eﬀacement 
is associated with detachment of podocytes 
from the glomerular basement membrane, 
loss of slit diaphragms and their replace-
ment by tight junctions, and development 
of proteinuria.
Foot process eﬀacement is a dynamic 
and reversible process and requires active 
interplay between the slit diaphragm pro-
teins and their extracellular ligands as well 
as their cytosolic eﬀectors that connect the 
protein complexes to signaling networks 
and actin cytoskeleton. Even though 
the regulation of actin polymerization/
depolymerization is well characterized, little 
has been known about the ligand-induced 
signaling events that regulate actin dynam-
ics in podocytes. Several recent publica-
tions, including the one by Uchida et al. in 
this issue of Kidney International,3 elegantly 
demonstrate the involvement of the slit dia-
phragm protein complexes in ‘outside-in’ 
signaling pathways that participate in the 
regulation of the actin cytoskeleton of the 
podocytes in health and disease.
The cytosolic domain of nephrin con-
tains several putative tyrosine phos-
phorylation sites1 that have emerged as 
important regulatory sites of nephrin 
function. Uchida et al. characterize two 
new phospho-nephrin-speciﬁc antibod-
ies that recognize rat nephrin, which is 
tyrosine phosphorylated on either residue 
Y1204 or Y1228, and show that nephrin 
is phosphorylated on these residues in 
normal rat glomeruli in vivo.3 Further, 
nephrin phosphorylation on these residues 
is decreased upon puromycin aminonucle-
oside (PAN)-induced podocyte damage 
and proteinuria. Already 1 day after PAN 
injection, and before the development of 
overt proteinuria, the level of phosphor-
ylated nephrin was signiﬁcantly decreased; 
it was hardly detectable after 7 and 14 days 
and returned back to the normal level 
28 days after PAN injection. The reduction 
reﬂects a decrease in nephrin phosphor-
ylation, as the reduction of total nephrin 
was less than that of its phosphorylated 
form. Supporting these ﬁndings, nephrin 
was shown to be phosphorylated in nor-
mal rat glomeruli, and this phosphoryla-
tion was decreased in PAN nephrosis.4–6 It 
has also been shown that nephrin tyrosine 
phosphorylation is minimal in normal 
rats but increases 3 days after induction of 
PAN nephrosis.7 In addition, in protamine 
sulphate-induced foot process eﬀacement 
in mice8 and passive Heymann nephritis in 
rats,9 nephrin phosphorylation increases. 
The above discrepancies may be explained 
by diﬀerences in the animal models and 
experimental protocols and antibodies 
used, but they may also reﬂect the dynamic 
nature of nephrin phosphorylation under 
changing circumstances. Nonetheless, the 
data indicate an important role for nephrin 
phosphorylation status in glomerular dis-
orders and call for careful time sequence 
studies on glomeruli in vivo, especially 
during disease progression and recov-
ery, and for the speciﬁc targeting of each 
phosphorylation site in nephrin.
Several of the tyrosine residues in 
the cytosolic domain of nephrin are 
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phosphorylated by Fyn and other Src 
family kinases,6,9,10 producing potential 
binding sites for SH2 domain-containing 
proteins. Accordingly, the SH2 and SH3 
domain-containing adaptor protein Nck 
has been identiﬁed as a binding partner of 
nephrin.4,8 The binding of Nck to nephrin 
is tyrosine phosphorylation dependent 
and is mediated via the SH2 domain of 
Nck. The SH3 domains of Nck in turn 
recruit proteins of the actin polymeriza-
tion machinery, including N-WASp and 
Arp2/3, to the complex (Figure 1). In line 
with this, engagement of nephrin extra-
cellular domain (by antibody-induced 
clustering) leads to nephrin tyrosine 
phosphorylation, recruitment of Nck to 
the complex, and induction of localized 
actin polymerization, indicating a role 
for nephrin and Nck in the regulation of 
actin polymerization. The essential role 
of Nck in podocytes is further substanti-
ated by the ﬁnding that lack of both Nck 
isoforms (Nck1/2) in podocytes leads to 
defects in foot process formation and to 
proteinuria.4
Whereas the above studies used cul-
tured cells to study the mechanisms by 
which nephrin regulates actin cytoskel-
eton, Uchida et al.3 took one step further 
to analyze actin dynamics in glomeruli 
in vivo in health and disease. They found 
that upon decreased nephrin phosphor-
ylation on Y1204 and Y1228, the amount 
of ﬁlamentous actin (F-actin) transiently 
decreased and globular actin (G-actin) 
increased in PAN nephrosis. Further, 
the decrease in F-actin appeared most 
prominent in podocytes. Interestingly, Li 
et al. show that these two residues, Y1204 
and Y1228 of rat nephrin (conserved in 
rat, mouse, and human), both contribute 
significantly to the binding of nephrin 
with Nck, and that Y1228 may be the pre-
ferred binding site in vivo.6 Additionally, 
nephrin–Nck interaction was reduced 
on day 7 of PAN nephrosis.6 Collectively, 
these ﬁndings suggest that reduced phos-
phorylation of nephrin on Y1228 may 
result in decreased binding of nephrin to 
Nck and alterations in actin polymeriza-
tion in podocytes.
In addition to Nck, phosphoinositide 
3-kinase (PI3K) provides an alternative 
pathway for nephrin-mediated regulation 
of the actin cytoskeleton (Figure 1). Tyro-
sine phosphorylation of nephrin increases 
its interaction with PI3K and induces acti-
vation of Akt and Rac1, both known regu-
lators of the actin cytoskeleton. This leads 
to a decrease in stress ﬁbers and an increase 
in membrane ruﬄes and lamellipodia in 
cultured podocytes.5 The mechanisms 
leading to decreased stress ﬁbers involve 
inactivation of RhoA, a small GTPase, and 
activation of cofilin, an actin filament-
severing protein. In PAN nephrosis, both 
nephrin–PI3K interaction and Akt activa-
tion decreased, supporting a role also for 
this actin regulatory pathway in modulat-
ing podocyte architecture and function.
Without any doubt, the regulation of 
podocyte function(s) is complex and 
requires cooperative mechanisms. This is 
well illustrated by Garg et al., who found 
that the nephrin homolog NEPH1 is phos-
phorylated by Fyn, leading to recruitment 
of Grb2 and localized actin polymeriza-
tion at the plasma membrane (Figure 1).7 
Furthermore, nephrin and NEPH1 
together were more potent in inducing 
actin polymerization than either of them 
alone, indicating a cooperative function 
for nephrin and NEPH1. In addition to 
immunoglobulin superfamily members, 
cadherin superfamily members also are 
components of the slit diaphragm and 
associate with the actin cytoskeleton and/
or proteins regulating actin (Figure 1) (for 
references, see Johnstone and Holzman2). 
Figure 1 | Signaling complexes regulating actin dynamics in the slit diaphragm. Several 
transmembrane proteins in the slit diaphragm associate with the actin cytoskeleton either 
directly or indirectly via cytosolic scaffolding proteins. Phosphorylation of the nephrin–NEPH1 
protein complex activates signaling pathways that cooperatively modulate actin organization 
in podocytes. FAT1 also associates with proteins that regulate actin polymerization.
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It should be noted that not all of the inter-
actions between the slit diaphragm pro-
teins and the cytoskeleton are regulated 
by phosphorylation. For example, nephrin 
and NEPH1 associate with CD2AP and 
ZO1, respectively, both of which are pro-
teins associating with actin (Figure 1) (for 
references, see Johnstone and Holzman2), 
and phosphorylation-dependent regula-
tory mechanisms have not been identi-
ﬁed for these interactions thus far. Thus 
the nephrin–NEPH1 protein complex 
has multiple ways to associate with and 
regulate the actin cytoskeleton. Further 
studies using cell culture and especially 
animal models are necessary to deﬁne the 
cooperative functions of the slit diaphragm 
protein complexes.
Finally, the key task is to define the 
molecular mechanisms regulating podo-
cyte actin dynamics during development 
of podocyte injury and proteinuria in var-
ious human glomerular diseases. Uchida 
et al. analyzed by immunoﬂuorescence 
microscopy seven minimal-change neph-
rosis patients for the presence of tyrosine-
phosphorylated nephrin in podocytes 
and found that the level of nephrin Y1228 
phosphorylation was signiﬁcantly lower 
than in control patients.3 Although the 
patient number was quite small, the 
result, together with studies on animal 
models and cultured cells, supports a 
role for the nephrin protein complex not 
only as a structural component of the 
slit diaphragm structure, but also as an 
active signaling scaﬀold modulating the 
structural and functional characteristics 
of podocytes. A further challenge will be 
to deﬁne the molecular mechanisms and 
signals from within the podocyte that 
regulate ligand engagement and func-
tional behavior of the slit diaphragm 
proteins.
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The treatment of acute interstitial 
nephritis: More data at last
GB Appel1
Acute interstitial nephritis (AIN) is an uncommon form of acute renal 
failure that is usually medication related. Although the clinical features 
and renal histopathology are well recognized, therapy beyond 
discontinuing the offending drug has been a challenge. The use of 
corticosteroids, although supported by numerous small retrospective 
studies and anecdotal case reports, has been controversial. The study by 
González et al., although it has limitations, provides solid support for the 
early use of corticosteroids in the treatment of drug-related AIN.
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Although the spectrum of acute interstitial 
nephritis (AIN) encompasses many enti-
ties, including sarcoidosis, tubulointerstitial 
nephritis and uveitis syndrome, lupus, and 
other autoimmune interstitial nephritides, 
medication-related AIN remains the most 
common and clinically relevant form 
in native kidneys.1–3 Although numer-
ous medications have been incriminated, 
methicillin and other β-lactam antibiot-
ics were the prototype oﬀending agents 
for many years.3 Studies documented an 
epidemiologic relationship between the 
renal lesion and the penicillin, there were 
cases with recurrence on rechallenge, and 
remissions of the clinical disease occurred 
when the offending agent was stopped. 
The classic clinical triad of rash, fever, and 
eosinophilia in a patient with acute renal 
failure, especially if non-oliguric, would 
prompt a search for urinary eosinophils 
and a discontinuation of methicillin or 
any other potential offending medica-
tion.3 Recent studies document that the full 
hypersensitivity triad is not often present, 
and suspicion of AIN must be present 
with any of these features in a patient with 
renal failure on suspect medications.1–4 
When nonsteroidal anti-inflammatory 
drugs (NSAIDs) were reported to have 
unique clinical features, such as onset of 
the nephrotic syndrome, in association 
with acute renal failure and AIN, this was 
rapidly absorbed by clinicians.3 Thus, clini-
cal criteria for medication-induced AIN 
have been established for years. Likewise, 
nephropathologists have become adept at 
diagnosing AIN and even predicting medi-
cations as the etiology of the AIN by noting 
not only ‘tubulitis,’ but eosinophilic inﬁl-
trates and at times granulomatous changes 
